Axogen

Axogen company information, Employees & Contact Information

Explore related pages

Related company profiles:

Axogen is the leading company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. We are passionate about helping to restore peripheral nerve function and quality of life to patients with physical damage or discontinuity to peripheral nerves by providing innovative, clinically proven and economically effective repair solutions for surgeons and health care providers. Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Physical damage to a peripheral nerve, or the inability to properly reconnect peripheral nerves, can result in the loss of muscle or organ function, the loss of sensory feeling, or the initiation of pain. Axogen’s comprehensive portfolio of products focuses on helping patients touch, run, feel, kiss, smile and hug—some of the many things healthy peripheral nerves allow us to do.

Company Details

Employees
524
Founded
-
Address
13631 Progress Blvd, Suite 400,united States
Phone
386-462-6800
Email
Cu****@****Inc.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Alachua, Fl
Looking for a particular Axogen employee's phone or email?

Axogen Questions

News

Axogen, Inc. to Report 2025 Third Quarter Financial Results on October 29, 2025 - Yahoo Finance

Axogen, Inc. to Report 2025 Third Quarter Financial Results on October 29, 2025 Yahoo Finance

Axogen, Inc. to Announce 2025 Second Quarter Financial Results on August 5, 2025 | AXGN Stock News - Quiver Quantitative

Axogen, Inc. to Announce 2025 Second Quarter Financial Results on August 5, 2025 | AXGN Stock News Quiver Quantitative

Nerve Surgery Leader Axogen Sets Q2 2025 Earnings Date: Key Financial Updates Coming August 5 - Stock Titan

Nerve Surgery Leader Axogen Sets Q2 2025 Earnings Date: Key Financial Updates Coming August 5 Stock Titan

Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences - GlobeNewswire

Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences GlobeNewswire

Axogen, Inc. Reports Second Quarter 2025 Financial Results - Yahoo Finance

Axogen, Inc. Reports Second Quarter 2025 Financial Results Yahoo Finance

Axogen, Inc. Receives FDA Extension for Avance® Nerve Graft Biologics License Application Review - Quiver Quantitative

Axogen, Inc. Receives FDA Extension for Avance® Nerve Graft Biologics License Application Review Quiver Quantitative

Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference - Yahoo Finance

Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference Yahoo Finance

Entry Recap: Can Axogen Inc. stock continue upward trend - July 2025 PreEarnings & Low Risk Investment Opportunities - Trung tâm Dự báo KTTV quốc gia

Entry Recap: Can Axogen Inc. stock continue upward trend - July 2025 PreEarnings & Low Risk Investment Opportunities Trung tâm Dự báo KTTV quốc gia

Axogen, Inc. Announces Analyst & Investor Day Scheduled for March 4, 2025 - Nasdaq

Axogen, Inc. Announces Analyst & Investor Day Scheduled for March 4, 2025 Nasdaq

AXGN Investors Have Opportunity to Join Axogen, Inc. Fraud Investigation with the Schall Law Firm - Business Wire

AXGN Investors Have Opportunity to Join Axogen, Inc. Fraud Investigation with the Schall Law Firm Business Wire

Axogen, Inc. Reports 2025 First Quarter Financial Results - GlobeNewswire

Axogen, Inc. Reports 2025 First Quarter Financial Results GlobeNewswire

Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results - GlobeNewswire

Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results GlobeNewswire

Axogen Provides Update on FDA Review Timeline for Avance Nerve Graft - GlobeNewswire

Axogen Provides Update on FDA Review Timeline for Avance Nerve Graft GlobeNewswire

Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia - Yahoo Finance

Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia Yahoo Finance

Axogen Announces Chief Financial Officer Transition - GlobeNewswire

Axogen Announces Chief Financial Officer Transition GlobeNewswire

When Will Axogen, Inc. (NASDAQ:AXGN) Breakeven? - Yahoo Finance

When Will Axogen, Inc. (NASDAQ:AXGN) Breakeven? Yahoo Finance

With 88% ownership of the shares, Axogen, Inc. (NASDAQ:AXGN) is heavily dominated by institutional owners - Yahoo Finance

With 88% ownership of the shares, Axogen, Inc. (NASDAQ:AXGN) is heavily dominated by institutional owners Yahoo Finance

FDA Pushes Axogen's Groundbreaking Nerve Graft Review to December Following New Manufacturing Data - Stock Titan

FDA Pushes Axogen's Groundbreaking Nerve Graft Review to December Following New Manufacturing Data Stock Titan

Axogen Inc (AXGN) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Progress Amid ... - Yahoo Finance

Axogen Inc (AXGN) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Progress Amid ... Yahoo Finance

Axogen Announces Independent Publication of Comparative Nerve Gap Repair Meta-Analysis of 35 peer-reviewed studies of Allograft, Autograft, and Conduits - Yahoo Finance

Axogen Announces Independent Publication of Comparative Nerve Gap Repair Meta-Analysis of 35 peer-reviewed studies of Allograft, Autograft, and Conduits Yahoo Finance

Can Axogen Inc. stock weather global recession - 2025 Volatility Report & Safe Swing Trade Setup Alerts - Trung tâm Dự báo KTTV quốc gia

Can Axogen Inc. stock weather global recession - 2025 Volatility Report & Safe Swing Trade Setup Alerts Trung tâm Dự báo KTTV quốc gia

Axogen, Inc. 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:AXGN) 2025-08-05 - Seeking Alpha

Axogen, Inc. 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:AXGN) 2025-08-05 Seeking Alpha

Axogen Completes Submission of Biologics License - GlobeNewswire

Axogen Completes Submission of Biologics License GlobeNewswire

Volume Report: How Axogen Inc. stock reacts to bond yields - July 2025 Setups & Safe Entry Point Alerts - Trung tâm Dự báo KTTV quốc gia

Volume Report: How Axogen Inc. stock reacts to bond yields - July 2025 Setups & Safe Entry Point Alerts Trung tâm Dự báo KTTV quốc gia

Is Axogen Inc. stock a buy before product launches - Market Risk Summary & High Conviction Buy Zone Picks - Trung tâm Dự báo KTTV quốc gia

Is Axogen Inc. stock a buy before product launches - Market Risk Summary & High Conviction Buy Zone Picks Trung tâm Dự báo KTTV quốc gia

With 88% ownership in Axogen, Inc. (NASDAQ:AXGN), institutional investors have a lot riding on the business - Sahm

With 88% ownership in Axogen, Inc. (NASDAQ:AXGN), institutional investors have a lot riding on the business Sahm

ArrowMark Colorado Holdings LLC Reduces Stake in Axogen Inc - Yahoo Finance

ArrowMark Colorado Holdings LLC Reduces Stake in Axogen Inc Yahoo Finance

When Can We Expect A Profit From Axogen, Inc. (NASDAQ:AXGN)? - simplywall.st

When Can We Expect A Profit From Axogen, Inc. (NASDAQ:AXGN)? simplywall.st

Axogen Inc opens state-of-the-art nerve repair facility in Vandalia - WKEF

Axogen Inc opens state-of-the-art nerve repair facility in Vandalia WKEF

Axogen to Participate at Upcoming Investor Conferences - GlobeNewswire

Axogen to Participate at Upcoming Investor Conferences GlobeNewswire

Is Axogen Inc. stock a buy before product launches - Market Performance Summary & Weekly Consistent Profit Watchlists - Fundação Cultural do Pará

Is Axogen Inc. stock a buy before product launches - Market Performance Summary & Weekly Consistent Profit Watchlists Fundação Cultural do Pará

AXGN Stock Price and Chart — NASDAQ:AXGN - TradingView

AXGN Stock Price and Chart — NASDAQ:AXGN TradingView

AxoGen to Present at Lazard Capital Markets Medical Technology Conference - AOL.com

AxoGen to Present at Lazard Capital Markets Medical Technology Conference AOL.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN - PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN PR Newswire

VIRGINIA RETIREMENT SYSTEMS ET Al Purchases New Shares in AxoGen, Inc. $AXGN - Defense World

VIRGINIA RETIREMENT SYSTEMS ET Al Purchases New Shares in AxoGen, Inc. $AXGN Defense World

Top Axogen Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant